Foot Locker, Inc. FL shares are trading lower in the premarket session on Thursday.
Shares of Foot Locker slumped nearly 15% in the past month, way lower than the broader S&P 500’s gain of over 2%.
Yesterday, the specialty athletic retailer reported fourth-quarter FY23 sales growth of 2% year-on-year to $2.38 billion, beating the analyst consensus estimate of $2.28 billion.
Comparable store sales decreased 0.7%. Adjusted EPS of $0.38 beat the analyst consensus of $0.32.
Mike Baughn, Executive Vice President and Chief Financial Officer, said, “We maintain conviction in the longer-term earnings potential that our Lace Up plan will generate and reiterate the 8.5-9% EBIT margin target communicated at our March 2023 Investor Day”.
“Given our lower starting point exiting 2023, we expect a two-year delay in achieving that goal and now see reaching that target by 2028,” Baughn added.
Last month, Foot Locker announced The Clinic, a year-long program with Nike, Inc. NKE and Jordan Brand, specifically meant for basketball fans, sneaker enthusiasts, and local communities.
Foot Locker sees FY24 comparable sales growth of 1% to 3%. FL expects sales to be -1% to +1%, representing $8.072 billion-$8.236 billion (consensus $8.02 billion).
Foot Locker expects Adjusted FY24 EPS of $1.50-$1.70 versus the consensus of $1.93.
Also Read: These Analysts Slash Their Forecasts On Foot Locker After Q4 Results
Price Action: FL shares are trading lower by 1.86% to $23.79 premarket on the last check Thursday.
Photo via Wikimedia Commons
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.